Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - Priority Announcement: Lymphoma (SHOPP)

University of Alberta

$67,500.00

Mechanism of B cell lymphoproliferative disease associated with hepatitis C infection

FY 2011-12

Summary
Approximately 170 million people worldwide are chronically infected with the hepatitis C virus (HCV), with thousands dying yearly from this disease. A subset of HCV patients develop serious complications ranging from skin rashes to joint pain to even kidney failure due to a specific autoimmune response by B cells, the white blood cells in our bodies that produce antibodies. These patients are also at much higher risk for developing B cell cancers. How HCV, and not other viruses, causes B cells to produce abnormal proteins called cryoglobulins is poorly understood. Cryoglobulins are the proteins causing inflammation and damage of tissues that over time can lead to the complications mentioned above. In this study we will first investigate how B cells are changed in HCV patients compared to hepatitis B virus (HBV) infected patients and uninfected, healthy controls. Next, we will determine how HCV affects B cell activation as we hypothesize that HCV directly stimulates B cells to produce cryoglobulins. Understanding how this process occurs can lead to novel drug treatments to prevent future complications for many patients with chronic HCV infection. In addition, our work could have broader implications in the understanding of B cell responses in patients with rheumatoid arthritis and lupus where cryoglobulins are also produced.
Program
Fellowship - Priority Announcement: Lymphoma (SHOPP)
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
243205
Name
Santer Deanna
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Lymphoma Foundation Canada (Mississauga)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Mechanism of B cell lymphoproliferative disease associated with hepatitis C infection
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$67,500
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Lymphoma (SHOPP)
Keyworddelim
Antibodies; B Cells And Lymphoma; Flow Cytometry; Hepatitis C Virus; Immunology; Inflammation; Molecular Biology
Abstract
Approximately 170 million people worldwide are chronically infected with the hepatitis C virus (HCV), with thousands dying yearly from this disease. A subset of HCV patients develop serious complications ranging from skin rashes to joint pain to even kidney failure due to a specific autoimmune response by B cells, the white blood cells in our bodies that produce antibodies. These patients are also at much higher risk for developing B cell cancers. How HCV, and not other viruses, causes B cells to produce abnormal proteins called cryoglobulins is poorly understood. Cryoglobulins are the proteins causing inflammation and damage of tissues that over time can lead to the complications mentioned above. In this study we will first investigate how B cells are changed in HCV patients compared to hepatitis B virus (HBV) infected patients and uninfected, healthy controls. Next, we will determine how HCV affects B cell activation as we hypothesize that HCV directly stimulates B cells to produce cryoglobulins. Understanding how this process occurs can lead to novel drug treatments to prevent future complications for many patients with chronic HCV infection. In addition, our work could have broader implications in the understanding of B cell responses in patients with rheumatoid arthritis and lupus where cryoglobulins are also produced.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Santer, Deanna
Approvedterm
3 ans 0 mois
Cihrcontribution2
SPIR~ $67,500~ $0~
University of Alberta - $67,500 Grant (2011-12) | Canada Spends